NXGL: NEXGEL Inc. Long-Term Debt Volume

Graphic logo of NEXGEL Inc (NXGL)

This chart of the market price for NEXGEL, Inc. (NXGL) is supplemented by long-term debt data, which stands at 0.01. NEXGEL, Inc. (NXGL) ensures the sterile transport of its products to clinics while maintaining strict climate control. Stable revenue is generated through multi-year agreements with pharmacy chains for the supply of hydrogel dressings. Simultaneously, the company is developing new polymer compositions for accelerated tissue healing, which continuously refreshes the product portfolio.

NXGL NEXGEL, Inc.: Company Long-Term Debts in the range 07/04/2022 - 10/29/2026

Analytical breakdowns for NEXGEL, Inc.

- price and consensus price forecast:
Share Price nexgel.com|NXGL - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization NEXGEL|NXGL - Enterprise Value
- book capitalization data:
Accounting Value per Share NEXGEL|NXGL - Book Capitalization|Market Capitalization to Book Value Ratio nexgel.com|NXGL - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity NEXGEL, Inc.|NXGL - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital NEXGEL Inc|NXGL - Company Aggregate Debts|Debts to Net Assets NEXGEL|NXGL - Company Long-Term Debt|Company Short-Term Indebtedness NEXGEL
General company analysis:nexgel.com (NXGL)
Mass-produced product of NEXGEL Inc

For the long-term investor, the reliability of NEXGEL, Inc. (NXGL) is determined by the balance between expansion and solvency. When analyzing the time series of the organization's long-term financial debt, one must consider the total liabilities with a maturity of more than one year, where an upward trend reflects either the scaling of hydrogel production for the B2B and B2C sectors or the risk of an excessive interest burden that reduces the business's financial independence.

Competitor analysis

Company Long-Term Indebtedness intuitive.com ISRG|Company Long-Term Debts DHR (Danaher)|BDX - Long-Term Debt Volume|STE (STERIS Corporation) - Company Long-Term Debts|West Pharma Corp (WST) - Company Long-Term Liabilities|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts MASI|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt Teleflex Inc. TFX|Company Long-Term Liabilities Merit Medical Systems Inc|Company Long-Term Loans and Borrowings Nobel Biocare NVST|Company Long-Term Debts ICUI (ICU Medical, Inc.)|XRAY: Long-Term Debt Volume|Company Long-Term Debt LeMaitre Vascular|ATRC (AtriCure Inc) - Company Long-Term Indebtedness|STAA: Company Long-Term Debt|Long-Term Debt Volume niagenbioscience.com (NAGE)|Company Long-Term Liabilities ZimVie Inc.|Amount of Long-Term Liabilities ANGO (angiodynamics.com)|Company Long-Term Debt Cerus|TKNO - Company Long-Term Loans and Borrowings|Monogram Technologies Inc - Company Long-Term Liabilities|STSS: Company Long-Term Debts|INFU (infusystem.com) - Company Long-Term Debt|utahmed.com (UTMD) - Company Long-Term Liabilities|Company Long-Term Debts KRMD (KORU Medical Systems, Inc.)|Long-Term Debt NYXH|Company Long-Term Debt Microbot Medical Inc MBOT|Company Long-Term Indebtedness Pro-Dex Inc. PDEX|Company Long-Term Liabilities Zentek Ltd. (ZTEK)|elutia.com - Amount of Long-Term Liabilities|Company Long-Term Debt MLSS (Milestone Scientific Inc.)|RVP: Long-Term Debt Volume|Company Long-Term Debt Harvard Bioscience, Inc.|Femasys Corporation (FEMY) - Company Long-Term Indebtedness|Company Long-Term Debts MHUA (Meihua Medical Technologies)|Long-Term Debt Predictive Oncology Corp (POAI)|Company Long-Term Liabilities Callan JMB Inc CJMB|Company Long-Term Indebtedness Atrion Corp. (ATRI)|NURO (NeuroMetrix Corp) - Company Long-Term Debts